26.04.2012
- Johnson & Johnson is sending in a former Army Ranger to clean up several big messes that have hurt its reputation, earnings and share price in the past three years. Alex Gorsky...
26.04.2012
- The Federal Trade Commission on Wednesday lost its latest attempt to thwart deals to delay the production of cheaper, generic drugs that brand-name drug companies make with...
24.04.2012
- Seven months after the acquisition of Rhodia, Solvay today presented the group's strategic vision focused on value creation and its profitability ambition for 2016. The major...
24.04.2012
- Watson Pharmaceuticals aims to announce an agreement to buy Actavis for around $6 billion on Wednesday, April 25th, in a deal making it one of the world's biggest suppliers of...
20.04.2012
- Roche dropped its bid to buy the gene-sequencing leader Illumina this week after Illumina's shareholders made it clear at the company's annual meeting that the terms were...
19.04.2012
- AkzoNobel, the world's largest paints maker and owner of the Dulux brand, warned that economic uncertainty - even in some emerging markets - as well as high raw materials prices...
19.04.2012
- BASF India will invest €150 million to set up a new chemical production site at the Dahej Petroleum, Chemicals and Petrochemicals Investment Region (PCPIR), located on the west...
19.04.2012
- Chemical maker Albemarle's first quarter earnings rose, and beat Wall Street's expectations, on strong sales of catalysts used by petroleum refiners. Sales of specialty materials...
18.04.2012
- Lanxess cooperates with biotechnology expert Evocatal in the development of biotechnological methods for the synthesis of precursors for the rubber production. The goal of the...
18.04.2012
- Abbott Laboratories reported better-than-expected quarterly sales and earnings, fueled by strong demand for its Humira arthritis drug and its wide array of prescription medicines...
